A phase I study of intravenous (IV) milataxel in combination with carboplatin in adult patients with advanced malignant solid tumors

被引：0
|
作者：
Flood, W. A. [1 ,2 ]
Lewis, L. D. [1 ,2 ]
机构：
[1] Penn State Hershey Canc Inst, Hershey, PA USA
[2] Dartmouth Med Sch, Lebanon, NH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13525
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase I study of intravenous (IV) milataxel in adult patients with advanced malignant tumors.
    Bourbouloux, E.
    Campone, M.
    Vermorken, J. B.
    Martin, M.
    Sessa, C.
    Perotti, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 88S - 88S
  • [2] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [3] Phase I combination study of trabectedin and carboplatin in advanced solid tumors
    Vidal, L.
    Garcia-Martin, M.
    Tan, S.
    Montes, A.
    Judson, I.
    Cuadra, C.
    Kaye, S.
    Flores, L.
    Izquierdo, M. A.
    Pardo, B.
    ANNALS OF ONCOLOGY, 2004, 15 : 106 - 106
  • [4] A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
    Mary E. R. O’Brien
    Debashis Sarker
    Jaishree Bhosle
    Kiruthikah Thillai
    Timothy A. Yap
    Martina Uttenreuther-Fischer
    Karine Pemberton
    Xidong Jin
    Sabrina Wiebe
    Johann de Bono
    James Spicer
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 757 - 766
  • [5] A phase I study to assess afatinib in combination with carboplatin or with carboplatin plus paclitaxel in patients with advanced solid tumors
    O'Brien, Mary E. R.
    Sarker, Debashis
    Bhosle, Jaishree
    Thillai, Kiruthikah
    Yap, Timothy A.
    Uttenreuther-Fischer, Martina
    Pemberton, Karine
    Jin, Xidong
    Wiebe, Sabrina
    de Bono, Johann
    Spicer, James
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (05) : 757 - 766
  • [6] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors
    Matsumoto, Koji
    Sunaga, Yoshinori
    Ecstein-Fraisse, Evelyne
    Fujiwara, Keiichi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 586 - 593
  • [8] Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
    M Harries
    A O'Donnell
    M Scurr
    S Reade
    C Cole
    I Judson
    A Greystoke
    C Twelves
    S Kaye
    British Journal of Cancer, 2004, 91 : 1651 - 1655
  • [9] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Elisabeth I. Heath
    George R. Blumenschein
    Roger B. Cohen
    Patricia M. LoRusso
    Noelle K. LoConte
    Sindy T. Kim
    Ana Ruiz-Garcia
    Richard C. Chao
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 703 - 712
  • [10] Sunitinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors: Updated phase I study results
    Heath, E. I.
    Blumenschein, G. R., Jr.
    Cohen, R. B.
    LoRusso, P. M.
    LoConte, N.
    Kim, S. T.
    Chao, R.
    Wilding, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345